Announcement: Regulating the Future of Healthy Longevity Therapies
Richard Barker announced his new global working group on healthy longevity regulation during a major conference at the Lithuanian Parliament — a pivotal step in bridging innovation and policy.
Natural Therapies and Longevity Science: Towards a Healthier, Longer Life
Natural remedies and longevity science increasingly intersect. From herbs and adaptogens to lifestyle medicine, Richard Barker explores what natural therapies may contribute to a longer, healthier life.
Lithuania – from Healthspan Laggard to Leader?
How Lithuania is building a blueprint for healthy longevity — combining genomics, lifestyle medicine, and ageing science. A closer look at the country’s emerging healthspan initiatives and what they reveal about Europe’s evolving longevity landscape.
Dublin Longevity Summit 2025: 9 Surprising Insights That Could Redefine Healthy Aging
What do bats, nanobots, and voice patterns have in common? Each revealed surprising insights at the 2025 Longevity Summit Dublin. Richard Barker shares 9 standout ideas that could transform how we think about aging, from organ rejuvenation to AI-powered prevention.
Leapfrogging in a Turbulent Healthcare World
Can innovation thrive amid political uncertainty? Richard Barker reflects on healthcare reform in Colombia, the role of digital tools in resource-constrained settings, and how bottom-up innovation may leapfrog more rigid systems.
Will AI Doctors Replace Clinicians — or Empower Them?
AI is transforming modern healthcare—but will it replace or empower clinicians? In this piece, Richard Barker explores how AI is reshaping diagnosis, post-op care, and mental health support, while underscoring the irreplaceable role of human judgement in personalised medicine.
Lisbon’s Longevity Summit: Lessons in Longevity Practicality
At Lisbon’s Longevity Med Summit, the message was clear: the future is already here. From biomarkers to breathwork, the tools for extending healthspan are no longer speculative — they’re practical, tested, and ready to use.
Blending Human and Machine Intelligence to Personalise Healthy Longevity
Explore two personalization strategies in healthy longevity: a data-driven “press-the-button” AI model versus Dr Ash Kapoor’s human-first “root-cause” narrative approach, enhanced by AI co-pilots. Which blend of human insight and machine intelligence will best guide your healthspan?
Dr Ash Kapoor on Root-Cause Longevity Medicine, Trauma & AI-Powered Care
In this conversation, Dr Ash Kapoor unveils his “root-cause” approach to longevity medicine—showing how deep patient narratives and trauma insights drive true personalization—and explores AI-powered, multidisciplinary care as the future of healthy aging.
Inside Miami’s Longevity & Skincare Summit: A Look at the Future of Skin Health
At the Innocos Conference on Longevity in Skincare, I explored how biomarkers, AI, and regenerative medicine are shaping the future of skin health. With longevity-based skincare innovation on the rise, how do we balance scientific validation with industry growth? Read my key takeaways from Miami.
The Next Frontier in Longevity: Highlights from the Hevolution Summit 2025
The Hevolution Summit 2025 in Riyadh brought together global experts to discuss the future of longevity, investment, and healthcare innovation. With Saudi Arabia's Vision 2030 healthcare plan, could the Kingdom become a leader in biomarker-driven longevity regulation? Explore key insights from the event, including breakthroughs in biotech, investment trends, and the challenges ahead.
Martin O’Dea on Biomarkers, Longevity Innovation & the Future of Aging Science
Biomarkers are transforming longevity science, offering a way to validate interventions, track biological aging, and shape future healthcare policies. In this interview, Martin O’Dea discusses the latest advancements in biomarker science, the role of AI-driven diagnostics, and the path toward regulatory acceptance. Watch now to explore the future of aging research.
Biomarkers: The Key to Unlocking Healthy Longevity
Since measurable biomarkers are essential for tracking biological aging, assessing disease risk, and validating longevity interventions, they are shaping the future of healthcare. In this article, I explore the challenges of biomarker standardization, recent advances in proteomics, and how biomarker-driven regulation could transform aging research.
Michael Ringel on Gaps in Aging Science, Public Engagement, and Advancing Longevity
In this exclusive interview, Michael Ringel, MD at BCG, discusses two of Richard Barker’s '10 Wicked Issues in Healthy Longevity.' Discover key insights into the gaps in aging science, the importance of public engagement, and the economic opportunities tied to advancing healthspan. A must-watch for anyone invested in the future of longevity.
Bridging Gaps in Healthy Longevity: Insights from the JPMorgan Conference
The annual JPMorgan Health Conference provides a unique opportunity to gauge the state of life sciences and healthcare innovation. This year, key gaps in AI adoption and prevention-focused longevity therapies stood out, alongside promising discussions on advancing healthy aging. Discover insights from the event, the rise of GLP-1 therapies, and strategies to bridge critical gaps in longevity science.
Tina Woods on Systemic Change and the Future of Longevity
Richard Barker and Tina Woods discuss systemic challenges in healthy aging, the exposomics' potential, the relaunch of the International Institute of Longevity, and a new Exposome Prize.
End of 2024: Reflecting on Progress and Looking Ahead to 2025
A race against time: Reflecting on progress in healthy longevity and the urgent need for breakthroughs as we look ahead to 2025.
Uncovering Hidden Patterns: AI's Impact in Bogotá and London
Exploring the intersection of data and innovation: How AI uncovers hidden patterns in healthcare and beyond, from Bogotá to London.
